BusinessVBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common SharesBy Nasdaq OMXOct 25, 2017, 8:01 PM UTC
BusinessILiAD Biotechnologies BPZE1 Pertussis Vaccine Reaches Key Milestones Including Positive Phase 1b Clinical Study DataBy Nasdaq OMXJul 5, 2017, 1:00 PM UTC
BusinessINC Research Bolsters Support for Vaccine Trials through Expanded Site and Patient InitiativesBy Nasdaq OMXApr 6, 2017, 6:53 PM UTC
BusinessHemispherx Biopharma Enters into Alfa-n3 Interferon Clinical Trial, Sales, Marketing, Distribution, and Supply Agreement with Saudi Arabia’s Premier Pharma Company in Fight Against the Deadly MERS DiseaseBy Nasdaq OMXApr 4, 2016, 12:30 PM UTC
BusinessPhase 1b Clinical Trial of BPZE1 Pertussis Vaccine Completes Enrollment of Randomized Study GroupsBy Nasdaq OMXFeb 19, 2016, 2:55 PM UTC
BusinessHemispherx Biopharma Exploring Possible Research Programs in Zika Virus Modeled on a Prior Alferon® N Clinical Trial on Closely Related Flavivirus (West Nile)By Nasdaq OMXFeb 9, 2016, 1:30 PM UTC
